Nymox Pharmaceutical (NYMX) Leaps on Study Results

Nymox Pharmaceutical Corporation

rose 10.4% to $4.91 after the company posted successful new long-term fexapotide placebo crossover study results. Share volume was 10.3 million, routing an all-day average of 689,000